CTIM-02. TIP: PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES

Authors: Colette Shen, Yara Abdou, Xianming Tan, Gaorav Gupta, Filipa Lynce, Erica Stringer-Reasor, Carey Anders

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.234

Source: Full article